BLRX · BioLineRX Ltd.
0.013
ILSUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
ILS37.82M
PE
0.00
EV/EBITDA
N/A
DIV Yield
0%
Payout Ratio
0%
MQV Rating
5Very Weak
As at 17/09/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- HALO All
- HALO Consensus Value
- HALO Earnings Momentum
- HALO Growth
- HALO Momentum
- HALO Price Momentum
- Near Support
Key Fundamentals
EPS 3 yr Growth
-98.50%
EBITDA Margin
-827.50%
Operating Cashflow
-$8m
Free Cash Flow Return
-34.60%
ROIC
-5.00%
Interest Coverage
-7.60
Quick Ratio
1.80
Performance
52 weeks range
Low 0.01 - 0.02
Trade Value (12mth)
US$5,549.00
1 week
0%
1 month
-13.33%
YTD
-13.33%
1 year
-40.91%
All time high
58.98
Additional Data
Shares Outstanding (Fully Diluted)
2,665m
HALO Sector
Healthcare
Next Company Report Date
30-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Very Strong
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| Lepu Medical Technology (Beijing) Co., Ltd. | Public Company |
| Philip Adam Serlin | Individual |
| Aharon Schwartz | Individual |
| Mali Zeevi | Individual |
| Ella Sorani | Individual |
